| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 05/01/2001 | US6225085 Nucleotide and amino acid sequence of leucine-rich surface glycoprotein; diagnosis; prophylaxis; therapy; drug screening; fusion proteins; antigenic peptides; antibodies; recombinant production |
| 05/01/2001 | US6225084 Nucleotide and amion acid sequence of genes that are up-regulated in endothelial cells subjected to shear stress; atherosclerosis, antiischemic agents; hypotensive agents; restenosis; antiinflammatory agents for arteries |
| 05/01/2001 | US6225083 Nucleotide and amino acid sequences of membrane protein involved in cell division; drug screening; bactericides; bacteriostats; antibiotics; for meningitis, sinusitis, conjunctivitis, otitis media, and endocarditis |
| 05/01/2001 | US6225082 Nucleic acid which is cis-acting messenger rna transport sequence; expression vectors; gene therapy |
| 05/01/2001 | US6225081 Protein, DNA coding for same and method of producing the protein |
| 05/01/2001 | US6225080 Nucleotide and amino acid sequence; for recombinant cell culture production; drug screening of ligands; studies of drug addiction; identifying other receptor subtypes |
| 05/01/2001 | US6225073 Immunoassay for mycophenolic acid |
| 05/01/2001 | US6225072 Process for the extraction of proteins |
| 05/01/2001 | US6225066 Determining drug resistance by incubating strain with drug and temperate mycobacteriophage permiting formation of lysogens which express reporter gene, then detecting transcription of reporter gene as indicator of resistance |
| 05/01/2001 | US6225054 Compositions and methods for the treatment and diagnosis of breast cancer |
| 05/01/2001 | US6225052 Method for determining a nucleic acid |
| 05/01/2001 | US6225049 Human insulinoma-associated cDNA |
| 05/01/2001 | US6225045 Drug screening of viricides against human immunodeficiency virus; incubating rev protein with nucleic acid having nucleation and oligomerization motifs in presence of candidate, detecting decreased binding as indicator |
| 05/01/2001 | US6225042 Culturing genetically engineered, antigen presenting insect cell line so that major histocompatibility class i molecules bound to selected peptide are produced on surface of cell, then contacting with cd8 t cells |
| 05/01/2001 | US6224902 Mixture of delivery vehicle and sterol |
| 05/01/2001 | US6224881 DNA molecule fragments encoding for cellular uptake of Mycobacterium tuberculosis and uses thereof |
| 05/01/2001 | US6224878 Culture product; genetic engineering |
| 05/01/2001 | US6224869 Isolated polypeptide |
| 05/01/2001 | US6224868 Reagent and processes for targeting mutant epidermal growth factor receptors |
| 05/01/2001 | US6224862 Mixture of prothrombinase and protein; anticoagulant |
| 05/01/2001 | US6224858 Hepatocytes transduced with a retroviral vector comprising splice sites and methods of expression |
| 05/01/2001 | US6224848 Pharmaceuticals providing diagnosis and selective tissue necrosis using Mossbauer absorber atom |
| 05/01/2001 | CA2286301A1 The filamentous phage as a multivalent scaffold for coupling synthetic peptides for immunization |
| 05/01/2001 | CA2195395C Cyclic hexapeptide somatostatin analogues |
| 05/01/2001 | CA2140624C P53 vaccine |
| 05/01/2001 | CA2081660C Method for improving the organoleptic qualities of the meat from uncastrated male domestic animals and vaccine set for use in this method |
| 05/01/2001 | CA2067333C Production of genetically-engineered vaccines for aids and retroviral diseases |
| 05/01/2001 | CA2046303C Il-1 biological activity inhibitors |
| 05/01/2001 | CA2001265C Analogs of peptidase substrates |
| 05/01/2001 | CA1341223C Dna clone of human tissue factor inhibitor |
| 05/01/2001 | CA1341222C Preparations of islet amyloid polypeptide (iapp) and antibodies to iapp |
| 05/01/2001 | CA1341220C Cloning and characterization of the bovine interleukin-2-gene |
| 05/01/2001 | CA1341219C Site specific mutagenesis in alpha-1-antitrypsin |
| 04/29/2001 | CA2322903A1 Treatment, diagnosis and evaluation of anti-cancer therapy resistance in melanoma |
| 04/29/2001 | CA2286401A1 Methods of diagnosing and treating melanoma utilizing tyrp2 |
| 04/27/2001 | CA2321975A1 Nucleotide sequences coding for the export of branched-chain amino acids, process for the isolation thereof and use thereof |
| 04/26/2001 | WO2001029564A1 Protein tyrosine kinase receptor polynucleotides, polypeptides, and antibodies |
| 04/26/2001 | WO2001029267A1 Methods for identifying and using maintenance genes |
| 04/26/2001 | WO2001029263A1 Drug target isogenes: polymorphisms in the 5-hydroxytryptamine (serotonin) receptor 1e gene |
| 04/26/2001 | WO2001029256A2 Cephalic pain susceptibility marker |
| 04/26/2001 | WO2001029255A2 Diagnostic test for cephalic pain |
| 04/26/2001 | WO2001029254A2 Identification of bpesc1, a gene disrupted by a balanced chromosomal translocation t(3;4) (q23;p15.2) in a patient with bpes |
| 04/26/2001 | WO2001029243A1 Method and vector for producing and transferring trans-spliced peptides |
| 04/26/2001 | WO2001029239A2 Modified resistance genes |
| 04/26/2001 | WO2001029235A2 Tms1 compositions and methods of use |
| 04/26/2001 | WO2001029233A2 Chimeric immunogenic compositions and nucleic acids encoding them |
| 04/26/2001 | WO2001029229A1 Novel polypeptide, human retinoblastoma binding protein 20 and polynucleotide encoding it |
| 04/26/2001 | WO2001029226A2 Apoptosis inducing proteinaceous substance |
| 04/26/2001 | WO2001029225A1 A general method for optimizing the expression of heterologous proteins |
| 04/26/2001 | WO2001029224A2 Granulocyte peptide homolog zgpa1 |
| 04/26/2001 | WO2001029223A2 Type i membrane protein ztsl1 |
| 04/26/2001 | WO2001029221A2 Proteins and polynucleotides encoding them |
| 04/26/2001 | WO2001029220A2 Mage-a12 antigenic peptides and uses thereof |
| 04/26/2001 | WO2001029219A1 Human cub-domain-containing protein and gene encoding the same |
| 04/26/2001 | WO2001029218A2 Nuclear matrix proteins, polynucleotide sequences encoding them, and their use |
| 04/26/2001 | WO2001029217A2 Novel polypeptides and polynucleotides encoding same |
| 04/26/2001 | WO2001029215A2 N-cam homolog and splice variants thereof |
| 04/26/2001 | WO2001029214A1 Colon-tumour-associated antigens |
| 04/26/2001 | WO2001029213A1 Human sit4 associated proteins like (sapl) proteins and encoding genes; uses thereof |
| 04/26/2001 | WO2001029210A1 A method for establishing connections between genes |
| 04/26/2001 | WO2001029204A2 Protein production system |
| 04/26/2001 | WO2001029201A1 Expression of recombinant mature lysostaphin |
| 04/26/2001 | WO2001029198A1 Polypeptide fragments comprising c-terminal portion of helicobacter catalase |
| 04/26/2001 | WO2001029197A2 Novel germinal center kinase cell cycle proteins, compositions and methods of use |
| 04/26/2001 | WO2001029194A1 Porcine endogenous retrovirus (poerv) expressed in guinea pig and corresponding animal models |
| 04/26/2001 | WO2001029183A2 Mutant lactic bacteria with a capacity for overexpressing at least one peptidase |
| 04/26/2001 | WO2001029179A2 Regulation of gene expression by neuromodulators |
| 04/26/2001 | WO2001029178A2 Epo primary response gene 1, eprg1 |
| 04/26/2001 | WO2001029177A2 Hiv-1 subtype d peptides |
| 04/26/2001 | WO2001029089A1 A RAT 7-TRANSMEMBRANE RECEPTOR, RATTUS rHNEAA81 |
| 04/26/2001 | WO2001029088A1 Novel genes encoding proteins having prognostic, diagnostic, preventive, therapeutic, and other uses |
| 04/26/2001 | WO2001029087A1 Transcription factor-selective nuclear transport receptors required for immune response activation |
| 04/26/2001 | WO2001029086A1 Peptides having corticotropin releasing factor (crf) antagonist activity |
| 04/26/2001 | WO2001029085A2 Cdt6 can inhibit angiogenesis and tumor growth, and can induce or enhance the formation of structures containing collagen v |
| 04/26/2001 | WO2001029084A2 Novel human proteins and polynucleotides encoding the same |
| 04/26/2001 | WO2001029083A1 POLYNUCLEOTIDES ENCODING HUMAN AND MURINE ADHESION PROTEINS (BIgR) |
| 04/26/2001 | WO2001029082A1 A DNA MOLECULE ENCODING A VARIANT α2B-ADRENOCEPTOR PROTEIN, AND USES THEREOF |
| 04/26/2001 | WO2001029081A1 Modified peptides and peptidomimetics for use in immunotherapy |
| 04/26/2001 | WO2001029080A1 A novel polypeptide - human high mobility group protein 13 and a polynucleotide encoding the same |
| 04/26/2001 | WO2001029079A1 IMMUNO-INTERACTIVE FRAGMENTS OF THE αC SUBUNIT OF INHIBIN |
| 04/26/2001 | WO2001029078A2 Method for production and use of mite group 1 proteins |
| 04/26/2001 | WO2001029077A1 A novel polypeptide-human beta 2 microglobin regulatory factor 34 and the polynucleotide encoding said polypeptide |
| 04/26/2001 | WO2001029076A1 A novel polypeptide-human p24 protein-22 and the polynucleotide encoding said polypeptide |
| 04/26/2001 | WO2001029075A1 A novel polypeptide-g-protein activating protein 129 and the polynucleotide encoding the polypeptide |
| 04/26/2001 | WO2001029074A1 Chimeric gene coding for a myb30 transcription factor and expression in plants |
| 04/26/2001 | WO2001029073A1 Methods for improving secondary metabolite production in fungi |
| 04/26/2001 | WO2001029072A2 P15paf cell cycle proteins associated with pcna, compositions and methods of use |
| 04/26/2001 | WO2001029071A2 Genes associated with obesity and methods for using the same |
| 04/26/2001 | WO2001029070A2 Modulation of t cell differentiation for the treatment of t helper cell mediated diseases |
| 04/26/2001 | WO2001029069A1 N-formyl peptide receptor complex with a g-protein kinase signal pathway modification agent |
| 04/26/2001 | WO2001029068A2 A eag gene encoding for a potassium channel |
| 04/26/2001 | WO2001029064A2 Melanoma antigens and methods of use |
| 04/26/2001 | WO2001029063A2 Death domain-containing receptor polynucleotides, polypeptides, and antibodies |
| 04/26/2001 | WO2001029062A2 Method for modulation of cell phenotype |
| 04/26/2001 | WO2001029058A1 Rna interference pathway genes as tools for targeted genetic interference |
| 04/26/2001 | WO2001029008A1 Pyrazole derivatives which modulate human serotonin receptors |
| 04/26/2001 | WO2001028586A1 Method of treating fibrosis |
| 04/26/2001 | WO2001028575A1 Proteoglycan, a bioactive substance from plants |
| 04/26/2001 | WO2001028540A2 Agent for treating cephalic pain |
| 04/26/2001 | WO2001028539A2 Agent for treating cephalic pain |